Key Details
Price
$79.85PE Ratio
32.73Annual ROE
8.47%Beta
0.50Events Calendar
Next earnings date:
Feb 25, 2025Recent quarterly earnings:
Nov 5, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 8, 2019Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein will stream a conference call for the fourth quarter and full-year 2024 on February 25, 2025.
An activist investor, Ananym Capital Management, intends to propose up to six new directors for the board of Henry Schein. They believe that the dental and medical distributor should look for a new CEO, reduce expenses, and improve how it uses its capital, according to three sources who are knowledgeable about the situation.
Henry Schein has finished acquiring Acentus, which will enhance its Home Solution business. This move will help Henry Schein grow and improve its services.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein has finished buying Acentus.
Henry Schein has carefully established distribution centers around the globe to improve customer service and enhance its operational efficiency.
Investors feel positive about HSIC because of how well its dental business is doing.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.
Ananym Capital is urging Henry Schein to make some changes that could enhance the company's profits.
Ananym Capital Management, an activist investor, is pushing healthcare products distributor Henry Schein to update its board, reduce expenses, address succession planning, and think about selling its medical distribution division, according to sources familiar with the situation.
FAQ
- What is the ticker symbol for Henry Schein?
- Does Henry Schein pay dividends?
- What sector is Henry Schein in?
- What industry is Henry Schein in?
- What country is Henry Schein based in?
- When did Henry Schein go public?
- Is Henry Schein in the S&P 500?
- Is Henry Schein in the NASDAQ 100?
- Is Henry Schein in the Dow Jones?
- When was Henry Schein's last earnings report?
- When does Henry Schein report earnings?
- Should I buy Henry Schein stock now?